We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VOD:LSEVodafone Group Public Limited Company Analysis

Data as of 2026-06-13 - not real-time

£115.75

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Vodafone (VOD.L) is trading at £115.75, notably below its DCF‑derived fair value of £123.87, implying a modest upside. The stock benefits from a low beta of 0.27 and a forward P/E of 10.5, well under the telecom sector average of 16.9, signalling relative cheapness. Volume is trending lower, yet liquidity remains solid, and technicals show a bullish MACD histogram with RSI around 57, supporting a neutral‑to‑positive short‑term outlook. Recent material news highlights Vodafone’s acquisition of the remaining stake in the VodafoneThree joint venture for £4.3 bn, a move expected to unlock synergies and reinforce its UK market position, while analysts note that the turnaround narrative is increasingly priced in.
The company’s dividend yield of 3.45% is attractive, but a payout ratio just above 100% raises questions about long‑term sustainability despite strong operating cash flow. High leverage (debt‑to‑equity ~100%) and a modest profit margin (‑0.98%) temper enthusiasm, though free cash flow remains healthy. Overall, the blend of valuation upside, dividend appeal, and strategic consolidation suggests a cautiously optimistic stance, with attention needed on debt servicing and dividend durability.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • DCF suggests price upside
  • Bullish MACD and neutral RSI
  • Strategic acquisition of VodafoneThree

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E well below industry
  • Synergy benefits from UK market consolidation
  • Strong operating cash flow supporting dividend

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High leverage and borderline dividend coverage
  • Stable telecom cash‑flow profile
  • Potential regulatory and geographic headwinds

Key Metrics & Analysis

Financial Health

Profit Margin-0.98%
P/E Ratio10.5
ROE0.11%
ROA1.52%
Debt/Equity100.15
P/B Ratio0.6
Op. Cash Flow£14.3B
Free Cash Flow£5.2B
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI57.2
Support£105.85
Resistance£131.10
MA 20£111.97
MA 50£114.40
MA 200£101.84
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value£123.87
Target Price£105.04
Upside/Downside-9.25%
GradeUndervalued
TypeValue
Dividend Yield3.45%

Risk Assessment

Beta0.27
Volatility33.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.